Retatrutide Nasal Spray

Buy Retatrutide Nasal Spray Online

Retatrutide has quickly become one of the most talked-about next-generation metabolic peptides. Its appeal comes from an unusual triple-receptor mechanism, combining GLP-1, GIP and glucagon activity in a single molecule.

Clinical research has produced substantial interest in retatrutide for weight management, appetite regulation and metabolic health.

Product Information

Retatrutide, also known as LY3437943, is an investigational peptide designed to activate three metabolic hormone receptors. Clinical studies have reported significant reductions in body weight alongside improvements in glucose-related measures.

How It Works

Retatrutide works by activating GLP-1, GIP, and glucagon receptors simultaneously. Together, these pathways influence appetite, glucose metabolism, and energy expenditure, creating a broader metabolic effect than compounds that target only one receptor.

Potential Benefits

1. Weight-Loss Research

Retatrutide has produced substantial reductions in body weight in clinical studies, generating major interest in next-generation weight-management treatments.

2. Appetite Control

Its GLP-1 and GIP activity makes retatrutide particularly interesting for research involving appetite and food-intake regulation.

3. Glucose Management

Clinical research has demonstrated meaningful improvements in blood-glucose measures, including HbA1c.

4. Fat-Metabolism Research

Its glucagon activity is believed to contribute to increased energy expenditure and changes in metabolic fuel utilization.

5. Broader Metabolic Effects

Research has also examined retatrutide's effects on triglycerides, liver fat and other cardiometabolic markers.

Dosage

Clinical trials have primarily studied once-weekly subcutaneous retatrutide, with dose-escalation protocols and doses ranging up to 12 mg in phase 2 research.

There is no clinically established nasal-spray dosage for retatrutide, so online intranasal dosing claims should not be confused with the dosing used in clinical trials.

Side Effects

The most commonly reported adverse effects in clinical research include nausea, diarrhea, vomiting, and constipation, particularly during dose escalation.

Where to Buy Retatrutide Nasal Spray

BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

References

Jastreboff AM, Kaplan LM, Frías JP, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine. 2023;389(6):514-526. PMID: 37366315. PubMed

Rosenstock J, Frías JP, Jastreboff AM, et al. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. The Lancet. 2023;402(10401):529-544. PMID: 37385280. PubMed

Please click here to access instructions on how to make a payment.

How to Pay